15 Jun 2011 10:06
PuriCore plc Results of 2011 Annual General Meeting
MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 15 June 2011 Ñ PuriCore(LSE: PURI), the water-based clean technology company focused on developing and commercialising proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, announces that Resolutions 1 to 8 were duly passed at its Annual General Meeting held earlier today. Proxy figures will be displayed shortly on the Company's investor website at http://investor.puricore.com.
The resolutions will be available shortly for inspection at the National Storage Mechanism at www.hemscott.com/nsm.do.
Enquiries:
Financial Dynamics Susan Quigley Ben Brewerton +44 (0) 20 7831 3113 | PuriCore Chris Wightman Executive Chairman +44 (0) 20 7290 3440 |
About PuriCore
PuriCore plc (LSE: PURI) is a water-based clean technology company focused on developing and commercialising proprietary green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment. PuriCoreÕs patented, proprietary technology mimics the human bodyÕs production of the natural antimicrobial hypochlorous acid, offering a safe and non-hazardous approach to disinfection and sanitisation. The CompanyÕs products are used in a broad range of markets that depend upon controlling contamination, including food retail and floral operations, wound care, and potential new applications in Agriculture. Hypochlorous acid is proven to be safe, environmentally friendly, and fast acting against a broad range of infectious pathogens, including major public health threats of C.difficile, E.coli, HIV, Human and Animal Influenza (including H1N1 and H5N1), Legionella, MRSA, M.tuberculosis, Norovirus, and Salmonella. PuriCore is headquartered in Malvern, Pennsylvania.
To receive additional information on PuriCore, please visit our website at www.puricore.com, which does not form part of this press release.